Загрузка...
Lorcaserin Treatment for Extended-Release Naltrexone Induction and Retention for Opioid Use Disorder Individuals: A Pilot, Randomized Trial
BACKGROUND: Opioid Use Disorder (OUD) is a significant public health problem associated with severe morbidity and mortality. While effective pharmacotherapies are available, limitations exist with each. Induction onto extended-release naltrexone (XR-NTX) is more difficult than initiation of buprenor...
Сохранить в:
| Опубликовано в: : | Drug Alcohol Depend |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7856237/ https://ncbi.nlm.nih.gov/pubmed/33418204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2020.108482 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|